PD Dr. Heiko Bruns

Department of Medicine 5 – Haematology and Oncology

Select hyperactivating NLRP3 ligands enhance the TH1-and TH17-inducing potential of human type 2 conventional dendritic cells (2022) Heger L, Hatscher L, Lehmann C, Purbojo A, Onderka C, Liang C, Hartmann A, et al. Conference contribution Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset. (2022) Böttcher M, Panagiotidis K, Bruns H, Stumpf M, Völkl S, Geyh S, Dietel B, et al. Journal article Physiological levels of 25-hydroxyvitamin D3 induce a suppressive CD4+ T cell phenotype not reflected in the epigenetic landscape (2022) Matos C, Renner K, Peuker A, Schoenhammer G, Schreiber L, Bruss C, Eder R, et al. Journal article Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021) Böttcher M, Bruns H, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, Büttner-Herold M, et al. Conference contribution CD137 (4-1BB) triggering leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity (2021) Stoll A, Bruns H, Gamali S, Saul D, Fuchs M, Nimmerjahn F, Kunz M, et al. Conference contribution How does phagocytosis affect macrophages? (2021) Biedermann A, Flamann C, Mougiakakos D, Bitterer K, Leffler M, Kellner C, Peipp M, et al. Conference contribution Deciphering the role of HLA-DO in immune responses after allogeneic stem cell transplantation (2021) Zeun J, Flamann C, Neubeck S, Bausenwein J, Seyler L, Vogler T, Brey S, et al. Conference contribution Severity of COVID-19 disease is related to hyperactivation and altered migratory capacity of T cells (2021) Spörl S, Kremer AL, Aigner M, Eisenhauer N, Koch P, Meretuk L, Loeffler P, et al. Conference contribution β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression (2021) Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, Büttner-Herold M, Bach C, Spriewald B, et al. Journal article Select hyperactivating NLRP3 ligands enhance the TH1-and TH17-inducing potential of human type 2 conventional dendritic cells (2021) Hatscher L, Lehmann C, Purbojo A, Onderka C, Liang C, Hartmann A, Cesnjevar R, et al. Journal article, Original article